COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

IVERMECTIN Testimonial - Stage 4 Melanoma patient (young female) has improvement in lung and liver lesions after conventional immunotherapy reached its limit

William Makis's avatar
William Makis
Dec 12, 2024
∙ Paid
Ivermectin, condemned by experts as COVID-19 treatment, continues to be  easily accessible through telemedicine - ABC News
User's avatar

Continue reading this post for free, courtesy of William Makis.

Or purchase a paid subscription.
© 2026 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture